These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Patent rights and the free research. The boundary between basic research and private sector is not longer razor-sharp]. Westerlund L Lakartidningen; 2005 Sep 26-Oct 2; 102(39):2737. PubMed ID: 16245544 [No Abstract] [Full Text] [Related]
25. Lymphokine racketeers? Cistron alleges foul play over IL-1, but Immunex sees it differently. Hopp TP Nat Biotechnol; 1996 Mar; 14(3):275-9. PubMed ID: 9630886 [No Abstract] [Full Text] [Related]
26. Intellectual property. NIH roils academe with advice on licensing DNA patents. Malakoff D Science; 2004 Mar; 303(5665):1757-8. PubMed ID: 15031474 [No Abstract] [Full Text] [Related]
27. Nontraditional publications and their effect on patentable inventions. Garabedian TE Nat Biotechnol; 2002 Apr; 20(4):401-2. PubMed ID: 11923849 [No Abstract] [Full Text] [Related]
28. Patent law. New rules for German professors. Kilger C; Bartenbach K Science; 2002 Nov; 298(5596):1173-5. PubMed ID: 12424355 [No Abstract] [Full Text] [Related]
29. Japan's novelty grace period solves the dilemma of 'publish and perish'. Tessensohn JA; Yamamoto S Nat Biotechnol; 2007 Jan; 25(1):55-7. PubMed ID: 17211396 [No Abstract] [Full Text] [Related]
30. Bayh-Dole: if we knew then what we know now. Boettiger S; Bennett AB Nat Biotechnol; 2006 Mar; 24(3):320-3. PubMed ID: 16525405 [No Abstract] [Full Text] [Related]
31. Research interactions between industry and academia: a corporate perspective. Citron P Physiologist; 1996 Jun; 39(3):81, 90-2. PubMed ID: 16764116 [No Abstract] [Full Text] [Related]
32. Rush to protect lucrative antibody patents kicks into gear. Ledford H Nature; 2018 May; 557(7707):623-624. PubMed ID: 29844545 [No Abstract] [Full Text] [Related]
33. In search of a compromised solution to the problem arising from patenting biomedical research tools. Derzko NM Santa Clara Comput High Technol Law J; 2004; 20(2):347-410. PubMed ID: 16493840 [No Abstract] [Full Text] [Related]
35. Researcher sues university over rights to transgenic technology. Dalton R Nature; 1999 Aug; 400(6745):601. PubMed ID: 10458144 [No Abstract] [Full Text] [Related]
37. Patents on parts of the human body: salient issues under EC and WTO law. Herdegen M J World Intellect Prop; 2002 Mar; 5(2):145-55. PubMed ID: 15986546 [No Abstract] [Full Text] [Related]
38. IP policies and serving the public. Beachy RN Science; 2003 Jan; 299(5606):473. PubMed ID: 12543937 [No Abstract] [Full Text] [Related]
39. The written-description requirement in UC v. Lilly. Levine HW Nat Biotechnol; 1998 Jan; 16(1):87-8. PubMed ID: 9447600 [No Abstract] [Full Text] [Related]